• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Elucidation of our recent findings on the protective role of prion protein against lethal infection with influenza A viruses is useful for development of a new type of anti-influenza drugs

Research Project

Project/Area Number 15K15380
Research Category

Grant-in-Aid for Challenging Exploratory Research

Allocation TypeMulti-year Fund
Research Field Infectious disease medicine
Research InstitutionThe University of Tokushima

Principal Investigator

SAKAGUCHI Suehiro  徳島大学, 先端酵素学研究所(次世代), 教授 (60274635)

Co-Investigator(Kenkyū-buntansha) 矢野 雅司  徳島大学, 先端酵素学研究所(次世代), 技術専門職員 (10531858)
Project Period (FY) 2015-04-01 – 2017-03-31
Project Status Completed (Fiscal Year 2016)
Budget Amount *help
¥3,640,000 (Direct Cost: ¥2,800,000、Indirect Cost: ¥840,000)
Fiscal Year 2016: ¥1,820,000 (Direct Cost: ¥1,400,000、Indirect Cost: ¥420,000)
Fiscal Year 2015: ¥1,820,000 (Direct Cost: ¥1,400,000、Indirect Cost: ¥420,000)
Keywordsプリオン蛋白質 / インフルエンザ / インフルエンザウイルス / 活性酸素種 / 銅イオン / 銅/亜鉛依存性スーパーオキシドジスムターゼ / ノックアウトマウス / アポトーシス / 酸化ストレス / 抗体 / リード化合物
Outline of Final Research Achievements

Here we show that the cellular prion protein, PrPC, is expressed in lung epithelial cells. Compared with wild-type (WT) mice, PrPC-null mice (Prnp0/0) developed higher mortality after infection with influenza A viruses (IAVs). Infected Prnp0/0 lungs were severely injured, with higher apoptosis of the epithelial cells, and contained higher ROS than control WT lungs. Treatment with a ROS scavenger rescued Prnp0/0 mice from the lethal infection with IAV. These results indicate that PrPC provides a protection against lethal infection with IAVs by reducing ROS in infected lungs. Cu contents and the activity of anti-oxidant enzyme Cu/Zn-dependent superoxide dismutase, SOD1, were lower in Prnp0/0 lungs than in WT lungs. It is thus conceivable that PrPC functions to maintain Cu contents and regulate SOD1 in lungs, thereby reducing ROS in IAV-infected lungs and eventually protecting from lethal infection with IAVs, suggesting that PrPC might be a new target for anti-influenza therapeutics.

Report

(3 results)
  • 2016 Annual Research Report   Final Research Report ( PDF )
  • 2015 Research-status Report

Research Products

(4 results)

All 2017 2016 2015

All Journal Article Presentation

  • [Journal Article] Effects of prion protein devoid of the N-terminal residues 25-50 on prion pathogenesis in mice.2017

    • Author(s)
      Nandita Rani Das, Hironori Miyata, Hideyuki Hara, Keiji Uchiyama, Junji Chida, Masashi Yano, Hitomi Watanabe, Gen Kondoh, Suehiro Sakaguchi
    • Journal Title

      Arc. Virol.

      Volume: 印刷中 Pages: 1867-1876

    • DOI

      10.1007/s00705-017-3295-3

    • Related Report
      2016 Annual Research Report
    • Peer Reviewed / Int'l Joint Research / Acknowledgement Compliant
  • [Journal Article] Melanin or a Melanin-Like Substance Interacts with the N-Terminal Portion of Prion Protein and Inhibits Abnormal Prion Protein Formation in Prion-Infected Cells.2017

    • Author(s)
      Taichi Hamanaka, Keiko Nishizawa, Yuji Sakasegawa, Ayumi Oguma, Kenta Teruya, Hiroshi Kurahashi, Hideyuki Hara, Suehiro Sakaguchi, Katsumi Doh-ura
    • Journal Title

      J Virol.

      Volume: 印刷中

    • DOI

      10.1128/jvi.01862-16

    • Related Report
      2016 Annual Research Report
    • Peer Reviewed / Open Access / Int'l Joint Research
  • [Presentation] 蛋白質凝集体「プリオン」による抗インフルエンザウイルス活性機構の解明2016

    • Author(s)
      原英之、千田淳司、坂口末廣
    • Organizer
      第39回日本分子生物学会
    • Place of Presentation
      パシフィコ横浜(神奈川県横浜市)
    • Year and Date
      2016-11-30
    • Related Report
      2016 Annual Research Report
  • [Presentation] 次世代抗インフルエンザ薬の宿主ターゲット分子の発見とその治療効果2015

    • Author(s)
      坂口末廣
    • Organizer
      四国地区五大学 新技術説明会
    • Place of Presentation
      JST東京本部別館1Fホール(東京・市ヶ谷)
    • Year and Date
      2015-11-27
    • Related Report
      2015 Research-status Report

URL: 

Published: 2015-04-16   Modified: 2018-03-22  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi